DONATE
We need your support to fund research that helps dogs live longer, healthier lives.
Donate Today
01861-A: Preventing Heart Damage during Chemotherapy through Early Detection of Cardiotoxicity
Grant Status: Open
Grant Amount: $12,960
Dr. Leigh G. Griffiths, DVM, University of California, Davis
August 1, 2012 - July 31, 2013
Breed(s): -All Dogs
Disease(s): Ventricular Arrhythmias
Research Program Area: Oncology
Abstract
Doxorubicin is a commonly used chemotheraputic agent in veterinary oncology with efficacy in the treatment of many cancer types. It has been well documented that doxorubicin can cause toxic changes to the heart that can result in heart failure and even death. Abnormal heart rhythms can also occur, however in veterinary medicine, the extent of these abnormal heart rhythms has not been well documented. The purpose of this study is to evaluate the effect of doxorubicin on the occurrence of abnormal heart rhythms. The study additionally aims to evaluate the use of a biomarker for heart damage (cardiac Troponin I), as a measure of early heart muscle damage due to Doxorubicin toxicity and to determine whether serum level of this biomarker are correlated with early changes in heart function.
Support Research
You can make contributions to support the specific areas of research that match your interests or greatest health concern.
Participation Needed
Your help is needed with canine health research. DNA and tissue samples are needed from healthy dogs and dogs affected by certain diseases.
